Association of PARP-1, NF-κB, NF-κBIA and IL-6, IL-1β and TNF-α with Graves Disease and Graves Ophthalmopathy
Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor (NF-κBIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TN...
Saved in:
Published in | Gene Vol. 547; no. 2; pp. 226 - 232 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.09.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor (NF-κBIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α) and mostly accompanied by an ocular disorder, Graves Ophthalmopathy (GO). We hypothesize that there is a relationship between GD, GO, polymorphisms of inflammatory related genes and their association with cytokines, which may play important roles in autoimmune and inflammatory processes.
To confirm our hypothesis, we studied the polymorphisms and cytokine levels of 120 patients with GD and GO using PCR-RFLP and ELISA methods, respectively.
We found that patients with GG genotype and carriers of G allele of PARP-1 G1672A polymorphism are at risk in the group having GD (p=0.0007) while having GA genotype may be protective against the disease. PARP-1 C410T polymorphism was found to be associated with GO by increasing the risk by 1.7 times (p=0.004). Another risk factor for development of GO was the polymorphism of del/ins of NFkB1 gene (p=0.032) that increases the risk by 39%. Levels of cytokines were also elevated in patients with GD, but no association was found between levels of cytokines and the development of GO as there was no change in levels of cytokines.
We suggest that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy.
•Graves Disease is an autoinflammatory disease.•We studied the genetics of Graves Disease and Ophthalmopathy.•G allele carriers of PARP-1 G1672A polymorphism are at risk of having GD.•GA genotype of G1672A polymorphism may be protective against the disease.•Having polymorphism of del/ins in NFkB1 gene may increase the risk of having GO. |
---|---|
AbstractList | Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor (NF-κBIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α) and mostly accompanied by an ocular disorder, Graves Ophthalmopathy (GO). We hypothesize that there is a relationship between GD, GO, polymorphisms of inflammatory related genes and their association with cytokines, which may play important roles in autoimmune and inflammatory processes.
To confirm our hypothesis, we studied the polymorphisms and cytokine levels of 120 patients with GD and GO using PCR-RFLP and ELISA methods, respectively.
We found that patients with GG genotype and carriers of G allele of PARP-1 G1672A polymorphism are at risk in the group having GD (p=0.0007) while having GA genotype may be protective against the disease. PARP-1 C410T polymorphism was found to be associated with GO by increasing the risk by 1.7 times (p=0.004). Another risk factor for development of GO was the polymorphism of del/ins of NFkB1 gene (p=0.032) that increases the risk by 39%. Levels of cytokines were also elevated in patients with GD, but no association was found between levels of cytokines and the development of GO as there was no change in levels of cytokines.
We suggest that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy. Background Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor- Kappa B (NF- Kappa B), Nuclear Factor- Kappa B Inhibitor (NF- Kappa BIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1 beta (IL-1 beta ), Interleukin-6 (IL-6) and Tumor Necrosis Factor- alpha (TNF- alpha ) and mostly accompanied by an ocular disorder, Graves Ophthalmopathy (GO). We hypothesize that there is a relationship between GD, GO, polymorphisms of inflammatory related genes and their association with cytokines, which may play important roles in autoimmune and inflammatory processes. Subjects and methods To confirm our hypothesis, we studied the polymorphisms and cytokine levels of 120 patients with GD and GO using PCR-RFLP and ELISA methods, respectively. Results We found that patients with GG genotype and carriers of G allele of PARP-1 G1672A polymorphism are at risk in the group having GD (p=0.0007) while having GA genotype may be protective against the disease. PARP-1 C410T polymorphism was found to be associated with GO by increasing the risk by 1.7 times (p=0.004). Another risk factor for development of GO was the polymorphism of del/ins of NFkB1 gene (p=0.032) that increases the risk by 39%. Levels of cytokines were also elevated in patients with GD, but no association was found between levels of cytokines and the development of GO as there was no change in levels of cytokines. Conclusions We suggest that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy. Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor (NF-κBIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α) and mostly accompanied by an ocular disorder, Graves Ophthalmopathy (GO). We hypothesize that there is a relationship between GD, GO, polymorphisms of inflammatory related genes and their association with cytokines, which may play important roles in autoimmune and inflammatory processes.To confirm our hypothesis, we studied the polymorphisms and cytokine levels of 120 patients with GD and GO using PCR-RFLP and ELISA methods, respectively.We found that patients with GG genotype and carriers of G allele of PARP-1 G1672A polymorphism are at risk in the group having GD (p=0.0007) while having GA genotype may be protective against the disease. PARP-1 C410T polymorphism was found to be associated with GO by increasing the risk by 1.7 times (p=0.004). Another risk factor for development of GO was the polymorphism of del/ins of NFkB1 gene (p=0.032) that increases the risk by 39%. Levels of cytokines were also elevated in patients with GD, but no association was found between levels of cytokines and the development of GO as there was no change in levels of cytokines.We suggest that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy. Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor (NF-κBIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α) and mostly accompanied by an ocular disorder, Graves Ophthalmopathy (GO). We hypothesize that there is a relationship between GD, GO, polymorphisms of inflammatory related genes and their association with cytokines, which may play important roles in autoimmune and inflammatory processes. To confirm our hypothesis, we studied the polymorphisms and cytokine levels of 120 patients with GD and GO using PCR-RFLP and ELISA methods, respectively. We found that patients with GG genotype and carriers of G allele of PARP-1 G1672A polymorphism are at risk in the group having GD (p=0.0007) while having GA genotype may be protective against the disease. PARP-1 C410T polymorphism was found to be associated with GO by increasing the risk by 1.7 times (p=0.004). Another risk factor for development of GO was the polymorphism of del/ins of NFkB1 gene (p=0.032) that increases the risk by 39%. Levels of cytokines were also elevated in patients with GD, but no association was found between levels of cytokines and the development of GO as there was no change in levels of cytokines. We suggest that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy. •Graves Disease is an autoinflammatory disease.•We studied the genetics of Graves Disease and Ophthalmopathy.•G allele carriers of PARP-1 G1672A polymorphism are at risk of having GD.•GA genotype of G1672A polymorphism may be protective against the disease.•Having polymorphism of del/ins in NFkB1 gene may increase the risk of having GO. Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor (NF-κBIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α) and mostly accompanied by an ocular disorder, Graves Ophthalmopathy (GO). We hypothesize that there is a relationship between GD, GO, polymorphisms of inflammatory related genes and their association with cytokines, which may play important roles in autoimmune and inflammatory processes.BACKGROUNDGraves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor (NF-κBIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α) and mostly accompanied by an ocular disorder, Graves Ophthalmopathy (GO). We hypothesize that there is a relationship between GD, GO, polymorphisms of inflammatory related genes and their association with cytokines, which may play important roles in autoimmune and inflammatory processes.To confirm our hypothesis, we studied the polymorphisms and cytokine levels of 120 patients with GD and GO using PCR-RFLP and ELISA methods, respectively.SUBJECTS AND METHODSTo confirm our hypothesis, we studied the polymorphisms and cytokine levels of 120 patients with GD and GO using PCR-RFLP and ELISA methods, respectively.We found that patients with GG genotype and carriers of G allele of PARP-1 G1672A polymorphism are at risk in the group having GD (p=0.0007) while having GA genotype may be protective against the disease. PARP-1 C410T polymorphism was found to be associated with GO by increasing the risk by 1.7 times (p=0.004). Another risk factor for development of GO was the polymorphism of del/ins of NFkB1 gene (p=0.032) that increases the risk by 39%. Levels of cytokines were also elevated in patients with GD, but no association was found between levels of cytokines and the development of GO as there was no change in levels of cytokines.RESULTSWe found that patients with GG genotype and carriers of G allele of PARP-1 G1672A polymorphism are at risk in the group having GD (p=0.0007) while having GA genotype may be protective against the disease. PARP-1 C410T polymorphism was found to be associated with GO by increasing the risk by 1.7 times (p=0.004). Another risk factor for development of GO was the polymorphism of del/ins of NFkB1 gene (p=0.032) that increases the risk by 39%. Levels of cytokines were also elevated in patients with GD, but no association was found between levels of cytokines and the development of GO as there was no change in levels of cytokines.We suggest that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy.CONCLUSIONSWe suggest that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy. |
Author | Onaran, Ilhan Sultuybek, Gönül Kanigur Aydoğdu, Pinar Koc, Arzuhan Niyazoglu, Mutlu Tasan, Ertuğrul Dellal, Fatma Dilek Baykara, Onur |
Author_xml | – sequence: 1 givenname: Mutlu surname: Niyazoglu fullname: Niyazoglu, Mutlu email: mutluniyaz@hotmail.com organization: Istanbul Training and Research Hospital, Endocrinology Department, Istanbul, Turkey – sequence: 2 givenname: Onur surname: Baykara fullname: Baykara, Onur email: obaykara@istanbul.edu.tr organization: Istanbul University, Cerrahpasa Medical Faculty, Department of Medical Biology and Genetics, Istanbul, Turkey – sequence: 3 givenname: Arzuhan orcidid: 0000-0002-4022-1014 surname: Koc fullname: Koc, Arzuhan email: akoc87@gmail.com organization: Istanbul University, Cerrahpasa Medical Faculty, Department of Medical Biology and Genetics, Istanbul, Turkey – sequence: 4 givenname: Pinar orcidid: 0000-0003-3038-5119 surname: Aydoğdu fullname: Aydoğdu, Pinar email: aydogdupinar@gmail.com organization: Istanbul University, Cerrahpasa Medical Faculty, Department of Medical Biology and Genetics, Istanbul, Turkey – sequence: 5 givenname: Ilhan surname: Onaran fullname: Onaran, Ilhan email: ilonaran@istanbul.edu.tr organization: Istanbul University, Cerrahpasa Medical Faculty, Department of Medical Biology and Genetics, Istanbul, Turkey – sequence: 6 givenname: Fatma Dilek surname: Dellal fullname: Dellal, Fatma Dilek email: drdellal@yahoo.com organization: Ankara Training and Research Hospital, Endocrinology Department, Ankara, Turkey – sequence: 7 givenname: Ertuğrul surname: Tasan fullname: Tasan, Ertuğrul email: etasan@hotmail.com organization: Bezmialem Vakif University, Faculty of Medicine, Department of Internal Medicine, Istanbul, Turkey – sequence: 8 givenname: Gönül Kanigur surname: Sultuybek fullname: Sultuybek, Gönül Kanigur email: kanigur@istanbul.edu.tr organization: Istanbul University, Cerrahpasa Medical Faculty, Department of Medical Biology and Genetics, Istanbul, Turkey |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24956560$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u3CAUhVGVqpmkfYEuKi-7iB3AgLHUzTTNz0ijJqrSNWLg0mHkMRPwpMpjNcs8RJ4p9vxsukhYcNG937lI5xyhgza0gNBngguCiThdFH-ghYJiwgosClzKd2hEZFXnuH8foBEuK5kTQupDdJTSAveHc_oBHVJWc8EFHqG7cUrBeN350GbBZTfjXzc5Ocl-XuTPT9_3dTLOdGuzyTQXJ8NNnh83jdth_C_767t5dhn1PaTsh0-gE2zGu9b1at7NdbMMK93NHz6i9043CT7t6jH6fXF-e3aVT68vJ2fjaW4YrrrcuopxWVtMnKVGWAvGOg2l1LXAklrHOXdGO2FcOav0bFYyI2tiJNGm4oyWx-jrdu8qhrs1pE4tfTLQNLqFsE6K9m4Qjhnjb6JE0KqWmAr8NspZ_zsjUvTolx26ni3BqlX0Sx0f1N78HpBbwMSQUgSnjO82SXRR-0YRrIac1UINOashZ4WF6rPtpfQ_6X77q6JvWxH0tt97iCoZD60B6yOYTtngX5O_ABLFv7k |
CitedBy_id | crossref_primary_10_17116_terarkh2015871067_71 crossref_primary_10_1007_s11596_023_2708_7 crossref_primary_10_1111_sji_12471 crossref_primary_10_1016_j_eprac_2020_11_011 crossref_primary_10_1016_j_jns_2015_12_047 crossref_primary_10_1371_journal_pone_0137654 crossref_primary_10_1038_hgv_2014_16 crossref_primary_10_3892_etm_2017_4047 crossref_primary_10_1515_abm_2020_0008 crossref_primary_10_1155_2020_4748612 crossref_primary_10_1038_srep16672 crossref_primary_10_1007_s12031_019_01299_8 crossref_primary_10_1128_MMBR_00038_18 crossref_primary_10_3349_ymj_2017_58_6_1160 crossref_primary_10_3389_fcell_2024_1480950 crossref_primary_10_1007_s00417_021_05456_x crossref_primary_10_26442_terarkh201890104_39 crossref_primary_10_1016_j_prp_2024_155608 crossref_primary_10_1016_j_intimp_2015_09_004 crossref_primary_10_1016_j_theriogenology_2020_11_022 crossref_primary_10_1007_s12011_015_0455_8 crossref_primary_10_1139_cjpp_2016_0332 crossref_primary_10_5301_ijbm_5000267 crossref_primary_10_1038_s41598_018_20701_w |
Cites_doi | 10.1074/jbc.M106528200 10.1007/s10875-013-9906-1 10.1530/EJE-09-0600 10.1002/art.10864 10.1530/eje.0.1320668 10.1002/bies.20085 10.1073/pnas.170226797 10.1007/s001090000132 10.1016/S0889-8529(05)70130-4 10.1124/pr.54.3.375 10.1210/jc.2005-1689 10.1016/j.humimm.2010.01.023 10.1046/j.1365-2265.2003.01708.x 10.1101/gad.9.22.2723 10.1007/s10528-009-9302-y 10.17925/EE.2008.04.02.107 10.1038/eye.2009.244 10.1159/000099471 10.1530/eje.0.1430197 10.1046/j.1365-2249.2000.01335.x 10.1093/rheumatology/kei262 10.1371/journal.pone.0052298 10.1136/ard.2007.077040 10.1210/jcem-72-5-1113 10.1006/mgme.2000.3015 10.1016/S0165-6147(98)01193-6 10.1111/j.1742-4658.2005.04864.x 10.1038/nrd1718 10.1186/1471-2350-13-116 10.1016/j.diabres.2007.10.020 10.1007/s00296-008-0772-8 10.1080/07315724.2008.10719741 10.1016/0092-8674(86)90807-X 10.1007/s00018-002-8527-2 10.1007/BF03344951 10.1002/jcla.20379 10.1016/j.jns.2007.02.008 10.1007/BF03346682 10.1016/j.arcmed.2008.09.003 10.1038/sj.gene.6364418 10.1186/1756-6614-2-10 10.1097/MOP.0b013e32832cf824 10.1586/ecp.12.54 |
ContentType | Journal Article |
Copyright | 2014 Elsevier B.V. Copyright © 2014 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2014 Elsevier B.V. – notice: Copyright © 2014 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 8FD FR3 P64 RC3 7S9 L.6 |
DOI | 10.1016/j.gene.2014.06.038 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Genetics Abstracts Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE Genetics Abstracts AGRICOLA MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering Anatomy & Physiology Biology |
EISSN | 1879-0038 |
EndPage | 232 |
ExternalDocumentID | 24956560 10_1016_j_gene_2014_06_038 S0378111914007021 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -~X .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 5GY 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABFNM ABFRF ABGSF ABJNI ABLJU ABMAC ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACNCT ACRLP ADBBV ADEZE ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPCBC SSU SSZ T5K WH7 ZA5 ~G- .55 .GJ 29H 53G AAHBH AAQXK AATTM AAXKI AAYWO AAYXX ABDPE ABEFU ABWVN ACRPL ACVFH ADCNI ADIYS ADMUD ADNMO ADVLN AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRDE AGRNS AI. AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CITATION FEDTE FGOYB G-2 HLW HVGLF HZ~ MVM R2- SBG SEW SSH VH1 WUQ X7M XOL XPP Y6R ZGI ~KM CGR CUY CVF ECM EIF NPM 7X8 8FD FR3 P64 RC3 7S9 L.6 |
ID | FETCH-LOGICAL-c407t-df74589d01fd2c6ddecdfae38a96082df555fcaf6cf3b7abb34c891c81ac75423 |
IEDL.DBID | .~1 |
ISSN | 0378-1119 1879-0038 |
IngestDate | Fri Jul 11 11:02:28 EDT 2025 Fri Jul 11 11:26:45 EDT 2025 Fri Jul 11 03:41:26 EDT 2025 Thu Apr 03 07:04:29 EDT 2025 Tue Jul 01 01:22:47 EDT 2025 Thu Apr 24 22:56:45 EDT 2025 Fri Feb 23 02:23:22 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Graves Disease Graves Ophthalmopathy Cytokine GO NF-κB1A PCR-RFLP GAG IL-1β PARP-1 IL-6 NF-κB NLS SNP TNF-α TRAb GD Polymorphism |
Language | English |
License | Copyright © 2014 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c407t-df74589d01fd2c6ddecdfae38a96082df555fcaf6cf3b7abb34c891c81ac75423 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-3038-5119 0000-0002-4022-1014 |
PMID | 24956560 |
PQID | 1547544186 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2000150445 proquest_miscellaneous_1627980260 proquest_miscellaneous_1547544186 pubmed_primary_24956560 crossref_citationtrail_10_1016_j_gene_2014_06_038 crossref_primary_10_1016_j_gene_2014_06_038 elsevier_sciencedirect_doi_10_1016_j_gene_2014_06_038 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-09-01 |
PublicationDateYYYYMMDD | 2014-09-01 |
PublicationDate_xml | – month: 09 year: 2014 text: 2014-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Gene |
PublicationTitleAlternate | Gene |
PublicationYear | 2014 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Senturk, Kozaci, Kok, Kadikoylu, Bolaman (bb0230) 2003; 26 Huang, Yang, Yao, Wang, Liao, Huang (bb0225) 2008; 39 Kiziltunc, Basoglu, Avci, Capoglu (bb0235) 1999; 29 Infante, Llorca, Mateo, Rodrigues-Rodrigues, Quintana, Juan, Fernández-Viadero, Peña, Berciano, Combarros (bb0065) 2007; 23 Kurylowicz, Mis'kiewicz, Bar-Andziak, Nauman, Bednarczuk (bb0135) 2009; 2 Tsai, Tsai, Lin, Lin, Liu, Liao, Wan (bb0020) 2012; 13 Scerrino, Morfino, Paladino, Di Paola, Amodio, Gulotta, Bonventre (bb0010) 2012 Daroszewski, Pawlak, Karabon, Frydecka, Jonkisz, Slowik, Bolanowski (bb0155) 2009; 161 Yelamos, Olive (bb0050) 2002; 21 Verma, Stevenson, Schwarz, Van Antwerp, Miyamoto (bb0140) 1995; 9 Burch, Bahn (bb0005) 2006; 2 Celik, Akalin, Erbas (bb0105) 1995; 132 Liu, Lin, Wu, Liu, Wang, Tsai (bb0115) 2010; 24 Bartalena, Brogioni, Grasso (bb0080) 1993; 16 Schimke, Rieber, Rylaarsdam, Cabral-Marques, Hubbard, Puel, Kallmann, Sombke, Notheis, Schwarz, Kammer, Hökfelt, Repp, Picard, Casanova, Belohradsky, Albert, Ochs, Renner, Torgerson (bb0145) 2013; 33 Siddiqi, Monson, Wood (bb0095) 1999; 84 Wakelkamp, Bakker, Baldeschi, Wiersinga, Prummel (bb0270) 2003; 58 Infante, Juan, Mateo, Rodriguez-Rodriguez, Sanchez-Quintana, Llorca, Fontalba, Terrazas, Oterino, Berciano, Combarros (bb0075) 2007; 256 Sen, Baltimore (bb0120) 1986; 47 Zhu, Liu, Zhao, Jia, Cui, Ning (bb0160) 2010; 33 Laddha, Dwivedi, Begum (bb0250) 2012; 7 Tuncay, Okyay, Bardakci (bb0125) 2010; 48 Anvar, Khalilzadeh, Esteghamati, Esfahani, Rashidi, Etemadi, Mahmoudi, Amirzargar (bb0170) 2010; 24 Chopra, Sakane, Teco (bb0100) 1991; 72 Heemstra, Smit (bb0025) 2008; 4 Antonelli, Rotondi, Ferrari, Fallahi, Romagnani, Franceschini, Serio, Ferrannini (bb0265) 2006; 91 Salvi, Girasole, Pedrazzoni, Passeri, Giuliani, Minelli, Braverman, Roti (bb0090) 1996; 81 Cottet, Blanche, Verasdonck, Le Galli, Schächter, Bürkle, Muiras (bb0195) 2000; 78 García, Bodaño, Pablos, Gómez-Reino, Conde (bb0180) 2008; 67 Burkle (bb0055) 2005; 272 Onaran, Tezcan, Ozgononel, Cetin, Ozdemir, Kanigur-Sultuybek (bb0070) 2009; 29 Bartalena, Grasso, Brogioni (bb0085) 1994; 78 Comings, MacMurray (bb0210) 2000; 71 Nikitin, Chudakova, Strokov, Bursa, Chistiakov, Nosikov (bb0200) 2008; 79 Shen, Oesterling, Stromberg, Toborek, MacDonald, Hennig (bb0220) 2008; 27 Szabó, Dawson (bb0185) 1998; 19 Al-Humaidi (bb0245) 2000; 21 Zsuzsanna, Zoltan, Camelia, Corina, Anisie, Jozsef (bb0255) 2010 Wakelkamp, Gerding, van der Meer, Bakker, Prummel, Wiersinga (bb0260) 2000; 121 Liu, Li, Liu, Zhao, Cui, Ning (bb0165) 2010; 71 Bahn (bb0015) 2012; 5 Virag, Szabo (bb0040) 2002; 54 Hur, Sung, Shin, Park, Cheong, Bae (bb0205) 2006; 45 Pascual, L'opez-Nevot, C'aliz, Ferrer, Balsa, Pascual-Salcedo, Martin (bb0110) 2003; 48 Hassa, Covic, Hasan, Imhof, Hottiger (bb0190) 2001; 276 Gough (bb0030) 2000; 29-2 Hassa, Hottiger (bb0215) 2002; 59 Ame, Spenlehauer, de Murcia (bb0060) 2004; 26 Salvi, Pedrazzoni, Girasole, Giuliani, Minelli, Wall, Roti (bb0240) 2000; 143 Brown (bb0150) 2009; 21 Kurylowicz, Hiromatsu, Jurecka-lubieniecka, Kula, Kowalska, Ichimura, Koga, Kaku, Bar-Andziak, Nauman, Jarzab, Ploski, Bednarczuk (bb0130) 2007; 8 Liaudet, Soriano, Szabo, Virag, Mabley, Salzman, Szabo (bb0175) 2000; 97 Jagtap, Szabo (bb0045) 2005; 4 Kabalak (bb0035) 2009 Wakelkamp (10.1016/j.gene.2014.06.038_bb0260) 2000; 121 Tsai (10.1016/j.gene.2014.06.038_bb0020) 2012; 13 Pascual (10.1016/j.gene.2014.06.038_bb0110) 2003; 48 Hur (10.1016/j.gene.2014.06.038_bb0205) 2006; 45 Laddha (10.1016/j.gene.2014.06.038_bb0250) 2012; 7 Infante (10.1016/j.gene.2014.06.038_bb0065) 2007; 23 Szabó (10.1016/j.gene.2014.06.038_bb0185) 1998; 19 Kiziltunc (10.1016/j.gene.2014.06.038_bb0235) 1999; 29 Kurylowicz (10.1016/j.gene.2014.06.038_bb0135) 2009; 2 Tuncay (10.1016/j.gene.2014.06.038_bb0125) 2010; 48 Onaran (10.1016/j.gene.2014.06.038_bb0070) 2009; 29 Chopra (10.1016/j.gene.2014.06.038_bb0100) 1991; 72 Hassa (10.1016/j.gene.2014.06.038_bb0215) 2002; 59 Liu (10.1016/j.gene.2014.06.038_bb0165) 2010; 71 Liu (10.1016/j.gene.2014.06.038_bb0115) 2010; 24 Huang (10.1016/j.gene.2014.06.038_bb0225) 2008; 39 Brown (10.1016/j.gene.2014.06.038_bb0150) 2009; 21 Gough (10.1016/j.gene.2014.06.038_bb0030) 2000; 29-2 Al-Humaidi (10.1016/j.gene.2014.06.038_bb0245) 2000; 21 Sen (10.1016/j.gene.2014.06.038_bb0120) 1986; 47 Shen (10.1016/j.gene.2014.06.038_bb0220) 2008; 27 Zsuzsanna (10.1016/j.gene.2014.06.038_bb0255) 2010 Liaudet (10.1016/j.gene.2014.06.038_bb0175) 2000; 97 Daroszewski (10.1016/j.gene.2014.06.038_bb0155) 2009; 161 Anvar (10.1016/j.gene.2014.06.038_bb0170) 2010; 24 Salvi (10.1016/j.gene.2014.06.038_bb0240) 2000; 143 Yelamos (10.1016/j.gene.2014.06.038_bb0050) 2002; 21 Bartalena (10.1016/j.gene.2014.06.038_bb0085) 1994; 78 Heemstra (10.1016/j.gene.2014.06.038_bb0025) 2008; 4 Bartalena (10.1016/j.gene.2014.06.038_bb0080) 1993; 16 Infante (10.1016/j.gene.2014.06.038_bb0075) 2007; 256 Kabalak (10.1016/j.gene.2014.06.038_bb0035) 2009 Salvi (10.1016/j.gene.2014.06.038_bb0090) 1996; 81 Scerrino (10.1016/j.gene.2014.06.038_bb0010) 2012 Virag (10.1016/j.gene.2014.06.038_bb0040) 2002; 54 Verma (10.1016/j.gene.2014.06.038_bb0140) 1995; 9 Senturk (10.1016/j.gene.2014.06.038_bb0230) 2003; 26 Kurylowicz (10.1016/j.gene.2014.06.038_bb0130) 2007; 8 Zhu (10.1016/j.gene.2014.06.038_bb0160) 2010; 33 Burch (10.1016/j.gene.2014.06.038_bb0005) 2006; 2 Siddiqi (10.1016/j.gene.2014.06.038_bb0095) 1999; 84 Cottet (10.1016/j.gene.2014.06.038_bb0195) 2000; 78 Celik (10.1016/j.gene.2014.06.038_bb0105) 1995; 132 Comings (10.1016/j.gene.2014.06.038_bb0210) 2000; 71 Bahn (10.1016/j.gene.2014.06.038_bb0015) 2012; 5 Nikitin (10.1016/j.gene.2014.06.038_bb0200) 2008; 79 Schimke (10.1016/j.gene.2014.06.038_bb0145) 2013; 33 García (10.1016/j.gene.2014.06.038_bb0180) 2008; 67 Ame (10.1016/j.gene.2014.06.038_bb0060) 2004; 26 Burkle (10.1016/j.gene.2014.06.038_bb0055) 2005; 272 Hassa (10.1016/j.gene.2014.06.038_bb0190) 2001; 276 Jagtap (10.1016/j.gene.2014.06.038_bb0045) 2005; 4 Antonelli (10.1016/j.gene.2014.06.038_bb0265) 2006; 91 Wakelkamp (10.1016/j.gene.2014.06.038_bb0270) 2003; 58 |
References_xml | – volume: 16 start-page: 213 year: 1993 end-page: 218 ident: bb0080 article-title: Increased serum interleukin-6 concentrations in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentrations publication-title: J. Endocrinol. Inv. – volume: 23 start-page: 215 year: 2007 end-page: 218 ident: bb0065 article-title: Interaction between poly(ADP-Ribose) polymerase 1 and interleukin 1A genes is associated with Alzheimer's disease risk publication-title: Dement. Geriatr. Cogn. Disord. – volume: 24 start-page: 1058 year: 2010 end-page: 1063 ident: bb0170 article-title: Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes publication-title: Eye (Lond) – volume: 71 start-page: 397 year: 2010 end-page: 401 ident: bb0165 article-title: The association of interleukin-1alpha and interleukin-1beta polymorphisms with the risk of Graves' disease in a case–control study and meta-analysis publication-title: Hum. Immunol. – volume: 21 start-page: 639 year: 2000 end-page: 644 ident: bb0245 article-title: Serum cytokines levels in Graves' Disease publication-title: Saudi Med. J. – volume: 13 start-page: 116 year: 2012 ident: bb0020 article-title: Thymic stromal lymphopoietin gene promoter polymorphisms and expression levels in Graves' disease and Graves' ophthalmopathy publication-title: BMC Med. Genet. – volume: 33 start-page: 1088 year: 2013 end-page: 1099 ident: bb0145 article-title: A novel gain-of-function IKBA mutation underlies ectodermal dysplasia with immunodeficiency and polyendocrinopathy publication-title: J. Clin. Immunol. – volume: 29 start-page: 25 year: 1999 end-page: 29 ident: bb0235 article-title: Serum IL-6 and TNF-a in patients with thyroid disorders publication-title: Tr. J. Med. Sci. – volume: 48 start-page: 104 year: 2010 end-page: 112 ident: bb0125 article-title: Identification of NF-kB1 and NF-kBIA polymorphisms using PCR-RFLP Assay in a Turkish population publication-title: Biochem. Genet. – volume: 48 start-page: 638 year: 2003 end-page: 641 ident: bb0110 article-title: A poly(ADP-ribose) polymerase haplotype spanning the promoter region confers susceptibility to rheumatoid arthritis publication-title: Arthritis Rheum. – volume: 26 start-page: 58 year: 2003 end-page: 63 ident: bb0230 article-title: Proinflammatory cytokine levels in hyperthyroidism publication-title: Clin. Invest. Med. – volume: 78 start-page: 423 year: 1994 end-page: 427 ident: bb0085 article-title: Serum interleukin-6 in amiodarone-induced thyrotoxicosis publication-title: J. Clin. Endocrinol. Metab. – volume: 132 start-page: 668 year: 1995 end-page: 672 ident: bb0105 article-title: Serum levels of interleukin (IL)-6 and tumor necrosis factor-α in hyperthyroid patients before and after propylthiouracil treatment publication-title: Eur. J. Endocrinol. – volume: 26 start-page: 882 year: 2004 end-page: 893 ident: bb0060 article-title: The PARP superfamily publication-title: BioEssays – volume: 21 start-page: 523 year: 2009 end-page: 528 ident: bb0150 article-title: Autoimmune thyroid disease: unlocking a complex puzzle publication-title: Curr. Opin. Pediatr. – volume: 2 start-page: 2029 year: 2006 end-page: 2042 ident: bb0005 article-title: Graves ophthalmopathy publication-title: Endocrinology – volume: 58 start-page: 280 year: 2003 end-page: 287 ident: bb0270 article-title: TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients publication-title: Clin. Endocrinol. – volume: 24 start-page: 182 year: 2010 end-page: 186 ident: bb0115 article-title: Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer's disease publication-title: J. Clin. Lab. Ann. – volume: 7 start-page: e52298 year: 2012 ident: bb0250 article-title: Increased tumor necrosis factor (TNF)-a and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo publication-title: PLoS One – volume: 71 start-page: 19 year: 2000 end-page: 31 ident: bb0210 article-title: Molecular heterosis: a review publication-title: Mol. Genet. Metab. – volume: 47 start-page: 921 year: 1986 end-page: 928 ident: bb0120 article-title: Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappaB by a posttranslational mechanism publication-title: Cell – volume: 81 start-page: 2976 year: 1996 end-page: 2979 ident: bb0090 article-title: Increased serum concentrations of interleukin (IL)-6 and soluble IL-6 receptor in patients with Graves' disease publication-title: J. Clin. Endocrinol. Metab. – volume: 67 start-page: 631 year: 2008 end-page: 637 ident: bb0180 article-title: Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts publication-title: Ann. Rheum. Dis. – volume: 143 start-page: 197 year: 2000 end-page: 202 ident: bb0240 article-title: Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking publication-title: Eur. J. Endocrinol. – volume: 19 start-page: 287 year: 1998 end-page: 298 ident: bb0185 article-title: Role of poly(ADP-ribose) synthetase in inflammation and ischaemia–reperfusion publication-title: Trends Pharmacol. Sci. – volume: 45 start-page: 711 year: 2006 end-page: 717 ident: bb0205 article-title: Poly(ADP-ribose) polymerase (PARP) polymorphisms associated with 58 nephritis and arthritis in systemic lupus erythematosus publication-title: Rheumatology (Oxford) – volume: 21 start-page: 219 year: 2002 end-page: 227 ident: bb0050 article-title: Role of poly (ADP-ribose) polymerase-1 (PARP-1) in the inflammatory response publication-title: Immunologia – start-page: 801 year: 2010 ident: bb0255 article-title: Cytokine profile in Graves' ophthalmopathy patients publication-title: Endocr. Abstr. – volume: 29-2 start-page: 255 year: 2000 ident: bb0030 article-title: The genetic of Graves disease publication-title: Endocrinol. Metab. Clin. N. Am. – volume: 2 start-page: 10 year: 2009 ident: bb0135 article-title: Association of polymorphism in genes encoding κB inhibitors (IκB) with susceptibility to and phenotype of Graves' disease: a case–control study publication-title: Thyroid. Res. – volume: 91 start-page: 614 year: 2006 end-page: 620 ident: bb0265 article-title: Interferon-γ-inducible α-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-γ agonists publication-title: J. Clin. Endocrinol. Metab. – volume: 39 start-page: 775 year: 2008 end-page: 784 ident: bb0225 article-title: Activation and overexpression of PARP-1 in circulating mononuclear cells promote TNF-α and IL-6 expression in patients with unstable angina publication-title: Arch. Med. Res. – volume: 8 start-page: 532 year: 2007 end-page: 538 ident: bb0130 article-title: Association of NFKB1—94ins/del ATTg promoter polymorphism with susceptibility to and phenotype of Graves's Disease publication-title: Genes Immun. – start-page: 353 year: 2009 end-page: 360 ident: bb0035 article-title: Tiroid ve Otoimmünite publication-title: Tiroid El Kitabı – volume: 79 start-page: 446 year: 2008 end-page: 452 ident: bb0200 article-title: Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients publication-title: Diabetes Res. Clin. Pract. – year: 2012 ident: bb0010 article-title: Does thyroid surgery for Graves' disease improve health-related quality of life? publication-title: Surg. Today – volume: 5 start-page: 605 year: 2012 end-page: 660 ident: bb0015 article-title: Emerging pharmacotherapy for treatment of Graves' disease publication-title: Expert. Rev. Clin. Pharmacol. – volume: 59 start-page: 1534 year: 2002 end-page: 1553 ident: bb0215 article-title: The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NFк-B in inflammatory disorders publication-title: Cell. Mol. Life Sci. – volume: 84 start-page: 435 year: 1999 end-page: 439 ident: bb0095 article-title: Serum cytokines in thyrotoxicosis publication-title: J. Clin. Endocrinol. Metab. – volume: 33 start-page: 751 year: 2010 end-page: 755 ident: bb0160 article-title: Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease publication-title: J. Endocrinol. Invest. – volume: 97 start-page: 10203 year: 2000 end-page: 10208 ident: bb0175 article-title: Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose) polymerase publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 78 start-page: 471 year: 2000 end-page: 480 ident: bb0195 article-title: New polymorphisms in the human poly (ADP-ribose) polymerase-1 coding sequence: lack of association with longevity or with increased cellular poly (ADP-ribosyl)ation capacity publication-title: J. Mol. Med. – volume: 4 start-page: 421 year: 2005 end-page: 440 ident: bb0045 article-title: Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors publication-title: Nat. Rev. Drug Discov. – volume: 256 start-page: 68 year: 2007 end-page: 70 ident: bb0075 article-title: Poly (ADP-ribose) polymerase-1 (PARP-1) genetic variants are protective against Parkinson's disease publication-title: J. Neurol. Sci. – volume: 276 start-page: 45588 year: 2001 end-page: 45597 ident: bb0190 article-title: The enzymatic and DNA binding activity of PARP-1 are not required for NF-kB coactivator function publication-title: J. Biol. Chem. – volume: 29 start-page: 797 year: 2009 end-page: 800 ident: bb0070 article-title: The Val762Ala polymorphism in the poly(ADP-ribose) polymerase-1 gene is not associated with susceptibility in Turkish rheumatoid arthritis patients publication-title: Rheumatol. Int. – volume: 72 start-page: 1113 year: 1991 end-page: 1116 ident: bb0100 article-title: A study of the serum concentration of tumor necrosis factor-α in thyroidal and nonthyroidal illnesses publication-title: J. Clin. Endocrinol. Metab. – volume: 4 start-page: 107 year: 2008 end-page: 109 ident: bb0025 article-title: Advances in the treatment of Graves' disease—a focus on Rituximab publication-title: Eur. Endocrinol. – volume: 54 start-page: 375 year: 2002 end-page: 429 ident: bb0040 article-title: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors publication-title: Pharmacol. Rev. – volume: 9 start-page: 2723 year: 1995 end-page: 2735 ident: bb0140 article-title: Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation publication-title: Genes Dev. – volume: 272 start-page: 4576 year: 2005 end-page: 4589 ident: bb0055 article-title: Poly (ADP-ribose). The most elaborate metabolite of NAD publication-title: Febs J. – volume: 27 start-page: 577 year: 2008 end-page: 587 ident: bb0220 article-title: Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappa B and PPAR signaling publication-title: J. Am. Coll. Nutr. – volume: 161 start-page: 787 year: 2009 end-page: 793 ident: bb0155 article-title: Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms publication-title: Eur. J. Endocrinol. – volume: 121 start-page: 453 year: 2000 end-page: 457 ident: bb0260 article-title: Both Th1 and Th2 derived cytokines in serum are elevated in Graves' ophthalmopathy publication-title: Clin. Exp. Immunol. – volume: 276 start-page: 45588 year: 2001 ident: 10.1016/j.gene.2014.06.038_bb0190 article-title: The enzymatic and DNA binding activity of PARP-1 are not required for NF-kB coactivator function publication-title: J. Biol. Chem. doi: 10.1074/jbc.M106528200 – volume: 33 start-page: 1088 year: 2013 ident: 10.1016/j.gene.2014.06.038_bb0145 article-title: A novel gain-of-function IKBA mutation underlies ectodermal dysplasia with immunodeficiency and polyendocrinopathy publication-title: J. Clin. Immunol. doi: 10.1007/s10875-013-9906-1 – volume: 161 start-page: 787 year: 2009 ident: 10.1016/j.gene.2014.06.038_bb0155 article-title: Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms publication-title: Eur. J. Endocrinol. doi: 10.1530/EJE-09-0600 – volume: 48 start-page: 638 issue: 3 year: 2003 ident: 10.1016/j.gene.2014.06.038_bb0110 article-title: A poly(ADP-ribose) polymerase haplotype spanning the promoter region confers susceptibility to rheumatoid arthritis publication-title: Arthritis Rheum. doi: 10.1002/art.10864 – volume: 132 start-page: 668 year: 1995 ident: 10.1016/j.gene.2014.06.038_bb0105 article-title: Serum levels of interleukin (IL)-6 and tumor necrosis factor-α in hyperthyroid patients before and after propylthiouracil treatment publication-title: Eur. J. Endocrinol. doi: 10.1530/eje.0.1320668 – volume: 26 start-page: 882 year: 2004 ident: 10.1016/j.gene.2014.06.038_bb0060 article-title: The PARP superfamily publication-title: BioEssays doi: 10.1002/bies.20085 – volume: 21 start-page: 219 issue: 4 year: 2002 ident: 10.1016/j.gene.2014.06.038_bb0050 article-title: Role of poly (ADP-ribose) polymerase-1 (PARP-1) in the inflammatory response publication-title: Immunologia – volume: 97 start-page: 10203 year: 2000 ident: 10.1016/j.gene.2014.06.038_bb0175 article-title: Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose) polymerase publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.170226797 – volume: 78 start-page: 471 year: 2000 ident: 10.1016/j.gene.2014.06.038_bb0195 article-title: New polymorphisms in the human poly (ADP-ribose) polymerase-1 coding sequence: lack of association with longevity or with increased cellular poly (ADP-ribosyl)ation capacity publication-title: J. Mol. Med. doi: 10.1007/s001090000132 – volume: 29-2 start-page: 255 year: 2000 ident: 10.1016/j.gene.2014.06.038_bb0030 article-title: The genetic of Graves disease publication-title: Endocrinol. Metab. Clin. N. Am. doi: 10.1016/S0889-8529(05)70130-4 – volume: 54 start-page: 375 year: 2002 ident: 10.1016/j.gene.2014.06.038_bb0040 article-title: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors publication-title: Pharmacol. Rev. doi: 10.1124/pr.54.3.375 – volume: 91 start-page: 614 issue: 2 year: 2006 ident: 10.1016/j.gene.2014.06.038_bb0265 article-title: Interferon-γ-inducible α-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-γ agonists publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2005-1689 – start-page: 353 year: 2009 ident: 10.1016/j.gene.2014.06.038_bb0035 article-title: Tiroid ve Otoimmünite – volume: 71 start-page: 397 issue: 4 year: 2010 ident: 10.1016/j.gene.2014.06.038_bb0165 article-title: The association of interleukin-1alpha and interleukin-1beta polymorphisms with the risk of Graves' disease in a case–control study and meta-analysis publication-title: Hum. Immunol. doi: 10.1016/j.humimm.2010.01.023 – volume: 58 start-page: 280 issue: 3 year: 2003 ident: 10.1016/j.gene.2014.06.038_bb0270 article-title: TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients publication-title: Clin. Endocrinol. doi: 10.1046/j.1365-2265.2003.01708.x – volume: 9 start-page: 2723 issue: 22 year: 1995 ident: 10.1016/j.gene.2014.06.038_bb0140 article-title: Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation publication-title: Genes Dev. doi: 10.1101/gad.9.22.2723 – volume: 48 start-page: 104 year: 2010 ident: 10.1016/j.gene.2014.06.038_bb0125 article-title: Identification of NF-kB1 and NF-kBIA polymorphisms using PCR-RFLP Assay in a Turkish population publication-title: Biochem. Genet. doi: 10.1007/s10528-009-9302-y – volume: 4 start-page: 107 issue: 2 year: 2008 ident: 10.1016/j.gene.2014.06.038_bb0025 article-title: Advances in the treatment of Graves' disease—a focus on Rituximab publication-title: Eur. Endocrinol. doi: 10.17925/EE.2008.04.02.107 – volume: 24 start-page: 1058 issue: 6 year: 2010 ident: 10.1016/j.gene.2014.06.038_bb0170 article-title: Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes publication-title: Eye (Lond) doi: 10.1038/eye.2009.244 – volume: 23 start-page: 215 year: 2007 ident: 10.1016/j.gene.2014.06.038_bb0065 article-title: Interaction between poly(ADP-Ribose) polymerase 1 and interleukin 1A genes is associated with Alzheimer's disease risk publication-title: Dement. Geriatr. Cogn. Disord. doi: 10.1159/000099471 – volume: 81 start-page: 2976 year: 1996 ident: 10.1016/j.gene.2014.06.038_bb0090 article-title: Increased serum concentrations of interleukin (IL)-6 and soluble IL-6 receptor in patients with Graves' disease publication-title: J. Clin. Endocrinol. Metab. – volume: 143 start-page: 197 year: 2000 ident: 10.1016/j.gene.2014.06.038_bb0240 article-title: Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking publication-title: Eur. J. Endocrinol. doi: 10.1530/eje.0.1430197 – start-page: 801 issue: 22 year: 2010 ident: 10.1016/j.gene.2014.06.038_bb0255 article-title: Cytokine profile in Graves' ophthalmopathy patients publication-title: Endocr. Abstr. – volume: 121 start-page: 453 year: 2000 ident: 10.1016/j.gene.2014.06.038_bb0260 article-title: Both Th1 and Th2 derived cytokines in serum are elevated in Graves' ophthalmopathy publication-title: Clin. Exp. Immunol. doi: 10.1046/j.1365-2249.2000.01335.x – volume: 45 start-page: 711 issue: 6 year: 2006 ident: 10.1016/j.gene.2014.06.038_bb0205 article-title: Poly(ADP-ribose) polymerase (PARP) polymorphisms associated with 58 nephritis and arthritis in systemic lupus erythematosus publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kei262 – volume: 7 start-page: e52298 issue: 12 year: 2012 ident: 10.1016/j.gene.2014.06.038_bb0250 article-title: Increased tumor necrosis factor (TNF)-a and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo publication-title: PLoS One doi: 10.1371/journal.pone.0052298 – volume: 67 start-page: 631 year: 2008 ident: 10.1016/j.gene.2014.06.038_bb0180 article-title: Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2007.077040 – volume: 2 start-page: 2029 year: 2006 ident: 10.1016/j.gene.2014.06.038_bb0005 article-title: Graves ophthalmopathy – volume: 72 start-page: 1113 year: 1991 ident: 10.1016/j.gene.2014.06.038_bb0100 article-title: A study of the serum concentration of tumor necrosis factor-α in thyroidal and nonthyroidal illnesses publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem-72-5-1113 – volume: 71 start-page: 19 year: 2000 ident: 10.1016/j.gene.2014.06.038_bb0210 article-title: Molecular heterosis: a review publication-title: Mol. Genet. Metab. doi: 10.1006/mgme.2000.3015 – volume: 19 start-page: 287 year: 1998 ident: 10.1016/j.gene.2014.06.038_bb0185 article-title: Role of poly(ADP-ribose) synthetase in inflammation and ischaemia–reperfusion publication-title: Trends Pharmacol. Sci. doi: 10.1016/S0165-6147(98)01193-6 – volume: 84 start-page: 435 year: 1999 ident: 10.1016/j.gene.2014.06.038_bb0095 article-title: Serum cytokines in thyrotoxicosis publication-title: J. Clin. Endocrinol. Metab. – volume: 272 start-page: 4576 issue: 18 year: 2005 ident: 10.1016/j.gene.2014.06.038_bb0055 article-title: Poly (ADP-ribose). The most elaborate metabolite of NAD+ publication-title: Febs J. doi: 10.1111/j.1742-4658.2005.04864.x – volume: 21 start-page: 639 issue: 7 year: 2000 ident: 10.1016/j.gene.2014.06.038_bb0245 article-title: Serum cytokines levels in Graves' Disease publication-title: Saudi Med. J. – volume: 4 start-page: 421 year: 2005 ident: 10.1016/j.gene.2014.06.038_bb0045 article-title: Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd1718 – volume: 13 start-page: 116 year: 2012 ident: 10.1016/j.gene.2014.06.038_bb0020 article-title: Thymic stromal lymphopoietin gene promoter polymorphisms and expression levels in Graves' disease and Graves' ophthalmopathy publication-title: BMC Med. Genet. doi: 10.1186/1471-2350-13-116 – volume: 79 start-page: 446 issue: 3 year: 2008 ident: 10.1016/j.gene.2014.06.038_bb0200 article-title: Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients publication-title: Diabetes Res. Clin. Pract. doi: 10.1016/j.diabres.2007.10.020 – volume: 29 start-page: 797 year: 2009 ident: 10.1016/j.gene.2014.06.038_bb0070 article-title: The Val762Ala polymorphism in the poly(ADP-ribose) polymerase-1 gene is not associated with susceptibility in Turkish rheumatoid arthritis patients publication-title: Rheumatol. Int. doi: 10.1007/s00296-008-0772-8 – volume: 27 start-page: 577 issue: 5 year: 2008 ident: 10.1016/j.gene.2014.06.038_bb0220 article-title: Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappa B and PPAR signaling publication-title: J. Am. Coll. Nutr. doi: 10.1080/07315724.2008.10719741 – volume: 26 start-page: 58 issue: 2 year: 2003 ident: 10.1016/j.gene.2014.06.038_bb0230 article-title: Proinflammatory cytokine levels in hyperthyroidism publication-title: Clin. Invest. Med. – volume: 47 start-page: 921 issue: 6 year: 1986 ident: 10.1016/j.gene.2014.06.038_bb0120 article-title: Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappaB by a posttranslational mechanism publication-title: Cell doi: 10.1016/0092-8674(86)90807-X – volume: 59 start-page: 1534 year: 2002 ident: 10.1016/j.gene.2014.06.038_bb0215 article-title: The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NFк-B in inflammatory disorders publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-002-8527-2 – volume: 16 start-page: 213 year: 1993 ident: 10.1016/j.gene.2014.06.038_bb0080 article-title: Increased serum interleukin-6 concentrations in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentrations publication-title: J. Endocrinol. Inv. doi: 10.1007/BF03344951 – year: 2012 ident: 10.1016/j.gene.2014.06.038_bb0010 article-title: Does thyroid surgery for Graves' disease improve health-related quality of life? publication-title: Surg. Today – volume: 24 start-page: 182 issue: 3 year: 2010 ident: 10.1016/j.gene.2014.06.038_bb0115 article-title: Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer's disease publication-title: J. Clin. Lab. Ann. doi: 10.1002/jcla.20379 – volume: 256 start-page: 68 year: 2007 ident: 10.1016/j.gene.2014.06.038_bb0075 article-title: Poly (ADP-ribose) polymerase-1 (PARP-1) genetic variants are protective against Parkinson's disease publication-title: J. Neurol. Sci. doi: 10.1016/j.jns.2007.02.008 – volume: 33 start-page: 751 issue: 10 year: 2010 ident: 10.1016/j.gene.2014.06.038_bb0160 article-title: Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease publication-title: J. Endocrinol. Invest. doi: 10.1007/BF03346682 – volume: 39 start-page: 775 issue: 8 year: 2008 ident: 10.1016/j.gene.2014.06.038_bb0225 article-title: Activation and overexpression of PARP-1 in circulating mononuclear cells promote TNF-α and IL-6 expression in patients with unstable angina publication-title: Arch. Med. Res. doi: 10.1016/j.arcmed.2008.09.003 – volume: 8 start-page: 532 issue: 7 year: 2007 ident: 10.1016/j.gene.2014.06.038_bb0130 article-title: Association of NFKB1—94ins/del ATTg promoter polymorphism with susceptibility to and phenotype of Graves's Disease publication-title: Genes Immun. doi: 10.1038/sj.gene.6364418 – volume: 2 start-page: 10 year: 2009 ident: 10.1016/j.gene.2014.06.038_bb0135 article-title: Association of polymorphism in genes encoding κB inhibitors (IκB) with susceptibility to and phenotype of Graves' disease: a case–control study publication-title: Thyroid. Res. doi: 10.1186/1756-6614-2-10 – volume: 21 start-page: 523 year: 2009 ident: 10.1016/j.gene.2014.06.038_bb0150 article-title: Autoimmune thyroid disease: unlocking a complex puzzle publication-title: Curr. Opin. Pediatr. doi: 10.1097/MOP.0b013e32832cf824 – volume: 5 start-page: 605 issue: 6 year: 2012 ident: 10.1016/j.gene.2014.06.038_bb0015 article-title: Emerging pharmacotherapy for treatment of Graves' disease publication-title: Expert. Rev. Clin. Pharmacol. doi: 10.1586/ecp.12.54 – volume: 29 start-page: 25 year: 1999 ident: 10.1016/j.gene.2014.06.038_bb0235 article-title: Serum IL-6 and TNF-a in patients with thyroid disorders publication-title: Tr. J. Med. Sci. – volume: 78 start-page: 423 year: 1994 ident: 10.1016/j.gene.2014.06.038_bb0085 article-title: Serum interleukin-6 in amiodarone-induced thyrotoxicosis publication-title: J. Clin. Endocrinol. Metab. |
SSID | ssj0000552 |
Score | 2.3040977 |
Snippet | Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor... Background Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor- Kappa B (NF- Kappa B), Nuclear... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 226 |
SubjectTerms | Adolescent Adult Aged Alleles Case-Control Studies Cytokine enzyme-linked immunosorbent assay Female Genetic Association Studies genotype Graves Disease Graves Ophthalmopathy Graves Ophthalmopathy - genetics Heterozygote Humans I-kappa B Proteins - genetics INDEL Mutation interleukin-1beta Interleukin-1beta - genetics interleukin-6 Interleukin-6 - genetics Male Middle Aged Mutation, Missense NF-kappa B - genetics NF-KappaB Inhibitor alpha PARP-1 patients Poly (ADP-Ribose) Polymerase-1 Poly(ADP-ribose) Polymerases - genetics polymerase chain reaction Polymorphism Polymorphism, Single Nucleotide restriction fragment length polymorphism risk factors transcription factor NF-kappa B tumor necrosis factor-alpha Tumor Necrosis Factor-alpha - genetics |
Title | Association of PARP-1, NF-κB, NF-κBIA and IL-6, IL-1β and TNF-α with Graves Disease and Graves Ophthalmopathy |
URI | https://dx.doi.org/10.1016/j.gene.2014.06.038 https://www.ncbi.nlm.nih.gov/pubmed/24956560 https://www.proquest.com/docview/1547544186 https://www.proquest.com/docview/1627980260 https://www.proquest.com/docview/2000150445 |
Volume | 547 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NThsxELYQCKk9VBTaEqDIlapeipt41944x4U2JG2VohYkbpZ_BRVsAoQDF94Jjn0Inqkee5dSqeTQy_7YY8nr8Y5n7JlvEHprlMsyQx3h2mrClKJEB8WEOFvYoBDkzie0z1ExOGCfD_nhHNppYmHArbKW_UmmR2ldl7Tr0WxPjo_bPzo5REkCPhlg1sRgcsa6MMs_XP9x8-hwnk4SwFoK1HXgTPLxCjwCqEzKIoYnxKj8e3F6TPmMi1B_CT2rtUdcpg4-R3OuWkYrZRUs59Mr_A5Hf864Ub6MFrebp6cPQAdX0NkDjuCxx3vl9z1Ct_CoT-5-bTf3YYlVZfHwKym24ErvbmPBPlTfYNi-xbuQuugCf0xnPLG6Lvo2OZoeqZPTMSQ8vnqBDvqf9ncGpE68QEyw76bE-i7jomc71NvMFEECGuuVy4UK9o7IrOece6N8YXyuu0rrnBnRo0ZQZSCjbv4SzVfjyq0i7IPGUZge044JlmmnvYVUFEx5mxtrdQvRZsSlqVHJITnGiWzcz35K4JIELknwwctFC72_bzNJmBwzqXnDSPnXzJJh0ZjZ7k3DdRl-OThHUZUbX17IoHUCbCAVxQyaIuv2BAC2PU6TxUD2DmO8hV6laXX_PZASHHCR1v6z9-voCbwlb7gNND89v3Svg_o01Zvx_9hEC-Xwy2D0G4D2GT8 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELaqVAg4IGh5BCgYCXGhVuJde-Mct4-Q0BAqSKXeLD_VonYTaHroz4IjP6K_qZ61txSJ5sBldzW2Ja_HHs_YM98g9NYol2WGOsK11YQpRYkOiglxtrBBIcidj2ifk2J4wD4e8sMVtN3EwoBbZZL9UabX0jpROmk0O_Pj487Xbg5RkoBPBpg1EEy-CuhUvIVWy9HecPJHIHMeLxPAYAoNUuxMdPMKbAK0TMpqGE8IU_n3_nSb_lnvQ4OH6EFSIHEZ-_gIrbhqDa2XVTCeTy_wO1y7dNZn5Wvozlbzdf8G7uA6-n6DKXjm8X75ZZ_QTTwZkMvfW817VGJVWTwak2ITnvTyV02YQvFPDCe4-ANkLzrDO_Gapy5OpM_zo8WROjmdQc7ji8foYLA73R6SlHuBmGDiLYj1PcZF33apt5kpghA01iuXCxVMHpFZzzn3RvnC-Fz3lNY5M6JPjaDKQFLd_AlqVbPKPUPYB6WjMH2mHRMs0057C9komPI2N9bqNqLNiEuTgMkhP8aJbDzQvkngkgQuSXDDy0Ubvb9uM4-wHEtr84aR8q_JJcO-sbTdm4brMqw6uEpRlZudn0kKEy1okqJYUqfIen0BmG2318nqWPYuY7yNnsZpdf0_kBUcoJGe_2fvX6O7w-mnsRyPJnsv0D0oic5xL1Fr8ePcbQRtaqFfpdVyBRYSG_A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+PARP-1%2C+NF-%CE%BAB%2C+NF-%CE%BABIA+and+IL-6%2C+IL-1%CE%B2+and+TNF-%CE%B1+with+Graves+Disease+and+Graves+Ophthalmopathy&rft.jtitle=Gene&rft.au=Niyazoglu%2C+Mutlu&rft.au=Baykara%2C+Onur&rft.au=Koc%2C+Arzuhan&rft.au=Aydo%C4%9Fdu%2C+Pinar&rft.date=2014-09-01&rft.pub=Elsevier+B.V&rft.issn=0378-1119&rft.eissn=1879-0038&rft.volume=547&rft.issue=2&rft.spage=226&rft.epage=232&rft_id=info:doi/10.1016%2Fj.gene.2014.06.038&rft.externalDocID=S0378111914007021 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-1119&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-1119&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-1119&client=summon |